Dr. Joao de Quevedo with UTHealth Houston shares what researchers found during a clinical trial for Spravato, the first FDA-approved nasal spray to treat depression.
A Senate committee in Virginia has advanced legislation that would fund clinical trials involving veterans and “breakthrough therapies” as designated by the Food and Drug Administration (FDA), ...
4 min read LIVE Justice Department Halts New Civil Rights Cases Trump’s Retreat From Clean Energy Puts the U.S. Out of Step With the World 4 min read ...
The presence of inflammatory cells in the brain may be one reason many drug treatments for depression fail ... with the vastly increased demands of new motherhood.